Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 733 publications

Determination of veliparib metabolic stability in the human liver microsomes using a hydrophilic interaction UPLC-MS/MS quantitative method: greenness assessment with an in silico study for ADME, DEREK alarms and metabolic lability.

Determination of veliparib metabolic stability in the human liver microsomes using a hydrophilic interaction UPLC-MS/MS quantitative method: greenness assessment with an in silico study for ADME, DEREK alarms and metabolic lability.

Journal: The Analyst
Published: November 13, 2025

Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models.

Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models.

Journal: Journal of medicinal chemistry
Published: November 10, 2025

Discovery of novel 2-azabicyclo[3.2.1]octane derivatives against non-small cell lung cancer from aconitine simplification.

Discovery of novel 2-azabicyclo[3.2.1]octane derivatives against non-small cell lung cancer from aconitine simplification.

Journal: Bioorganic chemistry
Published: October 30, 2025

Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database.

Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database.

Journal: Science progress
Published: October 15, 2025

Ceritinib overcomes proteasome inhibitor resistance in multiple myeloma by suppressing the protein folding response.

Ceritinib overcomes proteasome inhibitor resistance in multiple myeloma by suppressing the protein folding response.

Journal: Haematologica
Published: September 23, 2025

Ceritinib-ibuprofen synergistic hepatotoxicity: Insights from real-world data and liver organoid models.

Ceritinib-ibuprofen synergistic hepatotoxicity: Insights from real-world data and liver organoid models.

Journal: Toxicology
Published: August 31, 2025

Real-world costs, treatment patterns, and clinical outcomes associated with treatments for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.

Real-world costs, treatment patterns, and clinical outcomes associated with treatments for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.

Journal: Journal of managed care & specialty pharmacy
Published: August 30, 2025

A Triple Threat Against Ovarian Cancer: Os(II)-Pt(IV)-Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death Induction.

A Triple Threat Against Ovarian Cancer: Os(II)-Pt(IV)-Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death Induction.

Journal: Angewandte Chemie (International ed. in English)
Published: August 25, 2025

Vitamin-Integrated PROTAC Nanoparticle for Combined Therapy of NSCLC.

Vitamin-Integrated PROTAC Nanoparticle for Combined Therapy of NSCLC.

Journal: Langmuir : the ACS journal of surfaces and colloids
Published: August 14, 2025

Sex Differences in Cardiotoxicity of Anaplastic Lymphoma Kinase Inhibitors: An Analysis of the FDA Adverse Event Reporting System.

Sex Differences in Cardiotoxicity of Anaplastic Lymphoma Kinase Inhibitors: An Analysis of the FDA Adverse Event Reporting System.

Journal: Oncology
Published: July 24, 2025

Sensitive analysis of tyrosine kinase inhibitors in plasma using polypropylene fabric-solid phase extraction combined with liquid chromatography-tandem mass spectrometry.

Sensitive analysis of tyrosine kinase inhibitors in plasma using polypropylene fabric-solid phase extraction combined with liquid chromatography-tandem mass spectrometry.

Journal: Journal of chromatography. A
Published: July 17, 2025

Identification of plasma cell infiltration-related gene signatures as a novel prognostic model for clear cell renal cell carcinoma.

Identification of plasma cell infiltration-related gene signatures as a novel prognostic model for clear cell renal cell carcinoma.

Journal: Clinical and experimental medicine
Published: July 10, 2025
Showing 1-12 of 733

Last Updated: 01/07/2026